127.82
price up icon1.36%   +1.71
 
loading
DaVita Inc stock is currently priced at $127.82, with a 24-hour trading volume of 471.11K. It has seen a +1.36% increased in the last 24 hours and a -7.60% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $126.8 pivot point. If it approaches the $127.9 resistance level, significant changes may occur.

DaVita Inc Stock (DVA) Financials Data

DaVita Inc (DVA) Revenue 2024

DVA reported a revenue (TTM) of $12.14 billion for the quarter ending December 31, 2023, a +4.57% rise year-over-year.
loading

DaVita Inc (DVA) Net Income 2024

DVA net income (TTM) was $691.53 million for the quarter ending December 31, 2023, a +23.40% increase year-over-year.
loading

DaVita Inc (DVA) Cash Flow 2024

DVA recorded a free cash flow (TTM) of $1.49 billion for the quarter ending December 31, 2023, a +55.13% increase year-over-year.
loading

DaVita Inc (DVA) Earnings per Share 2024

DVA earnings per share (TTM) was $7.40 for the quarter ending December 31, 2023, a +28.03% growth year-over-year.
loading

DaVita Inc Stock (DVA) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
STAFFIERI MICHAEL DAVID
Chief Operating Officer, DKC
Mar 13 '24
Option Exercise
52.41
50,000
2,620,500
102,748
Rodriguez Javier
Chief Executive Officer
Mar 06 '24
Option Exercise
67.80
750,000
50,850,000
1,244,480
ACKERMAN JOEL
CFO and Treasuer
Mar 06 '24
Option Exercise
52.41
55,000
2,882,550
195,360
STAFFIERI MICHAEL DAVID
Chief Operating Officer, DKC
Mar 06 '24
Option Exercise
52.41
50,000
2,620,500
87,687
Rodriguez Javier
Chief Executive Officer
Feb 28 '24
Option Exercise
67.80
50,000
3,390,000
531,300
Rodriguez Javier
Chief Executive Officer
Feb 27 '24
Sale
126.87
7,397
938,467
481,300
Rodriguez Javier
Chief Executive Officer
Feb 26 '24
Option Exercise
67.80
450,000
30,510,000
889,002
Rodriguez Javier
Chief Executive Officer
Feb 26 '24
Sale
126.11
67,603
8,525,130
488,697
STAFFIERI MICHAEL DAVID
Chief Operating Officer, DKC
Feb 21 '24
Option Exercise
52.41
100,000
5,241,000
137,687
ACKERMAN JOEL
CFO and Treasuer
Feb 21 '24
Option Exercise
52.41
55,000
2,882,550
178,726
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company operates DaVita Rx, a pharmacy that provides oral medications and medication management services to patients with ESRD; disease management services; vascular access services; clinical research programs; physician services; and direct primary care services. As of December 31, 2017, it provided dialysis and administrative services in the United States through a network of 2,510 outpatient dialysis centers serving approximately 197,800 patients; and operated 237 outpatient dialysis centers located in 11 countries outside of the United States. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado.
medical_care_facilities FMS
$19.54
price up icon 0.77%
medical_care_facilities UHS
$157.47
price up icon 2.49%
medical_care_facilities THC
$93.19
price up icon 2.32%
medical_care_facilities CHE
$600.41
price up icon 0.50%
medical_care_facilities EHC
$79.22
price up icon 0.76%
Cap:     |  Volume (24h):